The DOI matches its Crossref record.
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration
Open accessAbstract
Tissue factor (TF), an initiator of the extrinsic coagulation cascade, is expressed in a wide range of cancer cells and plays important roles in cancer progression and metastasis. Recently, the intracellular function of TF has been revealed to be involved in cancer invasion, independent of the blood coagulation pathway. To evaluate the clinical significance of TF expression, we performed an enzyme-linked immunosorbent assay (ELISA) in the plasma of 67 breast cancer patients and immunohistochemistry in 213 breast cancer tissues. In the ELISA study, we showed an up-regulation of plasma TF concentration in breast cancer patients compared with normal controls. Immunohistochemistry demonstrated that TF was expressed in tumour cells and stromal cells and tumour TF expression closely correlated with stromal TF expression (P = 0.0005). The concentration of plasma TF was associated with tissue TF expression in both tumour and stroma. The multivariate analysis demonstrated that tumour TF expression was an independent prognostic indicator for overall survival (P = 0.0452). Our data show that plasma TF concentration reflects tissue TF expression and tumour TF expression can provide some predictive value for prognosis and distant metastasis, which indicates the importance of TF function in tumour progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirousková, M., & Degen, J. L. (2005) · Blood · doi:10.1182/blood-2004-06-2272 · Cited by 999
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Horwitz, K. B., & Wolf, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110090200 · Cited by 572
Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?
TESSELAAR, M. E. T., ROMIJN, F. P. H. T. M., VAN DER LINDEN, I. K., PRINS, F. A., BERTINA, R. M., & OSANTO, S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02369.x · Cited by 548
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Ay, C., Pabinger, I., & Cohen, A. T. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0615 · Cited by 496
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
Camerer, E., Qazi, A. A., Duong, D. N., Cornelissen, I., Advincula, R., & Coughlin, S. R. (2004) · Blood · doi:10.1182/blood-2004-02-0434 · Cited by 386
Tissue Factor, Thrombin, and Cancer
Rickles, F. R., Patierno, S., & Fernandez, P. M. (2003) · Chest · doi:10.1378/chest.124.3_suppl.58s · Cited by 378
The relationship between tissue factor and cancer progression: insights from bench and bedside
van den Berg, Y. W., Osanto, S., Reitsma, P. H., & Versteeg, H. H. (2012) · Blood · doi:10.1182/blood-2011-06-317685 · Cited by 354
Inhibition of tissue factor signaling suppresses tumor growth
Versteeg, H. H., Schaffner, F., Kerver, M., Petersen, H. H., Ahamed, J., Felding-Habermann, B., Takada, Y., Mueller, B. M., & Ruf, W. (2008) · Blood · doi:10.1182/blood-2007-07-101048 · Cited by 327
Pancreatic cancer and thromboembolic disease
Khorana, A. A., & Fine, R. L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01606-7 · Cited by 269
Expression of Tissue Factor in Prostate Cancer Correlates With Malignant Phenotype
Kaushal, V., Mukunyadzi, P., Siegel, E. R., Dennis, R. A., Johnson, D. E., & Kohli, M. (2008) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/01.pai.0000213157.94804.fc · Cited by 32
Metadata
- Authors
- Ueno, T., Toi, M., Koike, M., Nakamura, S., & Tominaga, T.
- Venue
- British Journal of Cancer
- Published
- 2000-07
- Volume
- 83
- Issue
- 2
- Pages
- 164-170
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1832657260
- Cited by
- 243
- References
- 0
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.